GSA Capital Partners LLP Makes New $599,000 Investment in Advanced Biomed Inc. $ADVB

GSA Capital Partners LLP bought a new position in Advanced Biomed Inc. (NASDAQ:ADVB) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 193,323 shares of the company’s stock, valued at approximately $599,000. GSA Capital Partners LLP owned about 0.12% of Advanced Biomed at the end of the most recent quarter.

Analyst Ratings Changes

Separately, Weiss Ratings raised shares of Advanced Biomed from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, July 23rd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Advanced Biomed currently has an average rating of “Sell”.

Advanced Biomed Stock Performance

Shares of ADVB opened at $8.19 on Friday. Advanced Biomed Inc. has a 52 week low of $3.61 and a 52 week high of $24.23. The stock has a market capitalization of $13.53 million, a price-to-earnings ratio of 1.70 and a beta of -0.39. The stock has a fifty day moving average of $7.17 and a 200-day moving average of $5.65.

Advanced Biomed Company Profile

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.